DME suppliers need senior financial leadership to manage payer mix, drive down denial rates, and enforce inventory discipline without the cost of a full-time CFO. We embed with your leadership team to stabilize collections, improve margin, and prepare operations for buyer scrutiny.
No cost. 15 minutes. No obligation.
DME suppliers need senior financial leadership to manage payer mix, drive down denial rates, and enforce inventory discipline without the cost of a full-time CFO. We embed with your leadership team to stabilize collections, improve margin, and prepare operations for buyer scrutiny.
Most DME suppliers run on Medicare and Medicaid reimbursement with commercial supplemental, operating on thin margins where a 2% shift in denial rate can eliminate profitability. Owners spend time firefighting claim denials and slow collections instead of managing payer relationships and inventory turns. Without dedicated financial leadership, billing accuracy drifts, A/R ages past 60 days, and inventory builds in low-turnover categories that tie up working capital. Buyers discount heavily when they see adverse payer mix, owner-dependent payer relationships, and uncollected receivables that signal operational risk.
Monthly collection rate and denial rate reporting by payer, with root cause analysis tied to billing staff and coder performance
Quarterly payer mix review and reimbursement modeling to shift volume toward commercial contracts and higher-margin product lines
Inventory turnover analysis by DME category with slow-moving SKU identification and capital redeployment recommendations
Days in A/R tracking with aging bucket protocols and systematic collections escalation by payer type
Cash flow forecasting aligned to Medicare payment cycles and Medicaid lag patterns specific to your state
Financial dashboard covering collection rate, denial rate, inventory turnover, payer mix percentage, and days in A/R for leadership review
Pre-diligence financial package documenting clean billing, managed payer relationships, and transferable collections infrastructure
Buyers in the DME space pay 3 to 12x EBITDA depending on subsegment, with commodity DME at 3 to 6x and respiratory or CPAP businesses commanding 7 to 12x due to recurring revenue and higher margins. Multiple expansion depends entirely on clean billing infrastructure, transferable payer relationships, and verifiable collections discipline. We build the financial infrastructure and documentation buyers require during diligence, including denial rate trending, payer mix stability, inventory discipline, and A/R aging that proves operational transferability without the owner.
fractional cfo services for durable medical equipment suppliers is the intersection page. Read the full durable medical equipment suppliers advisory angle, the general fractional cfo services overview, or run the Value Creation Assessment to see where your practice stands.
We implement weekly denial tracking by payer and product code, root cause analysis tied to specific billing errors, and coder accountability metrics that your existing team executes. Most DME denial rate problems stem from lack of visibility and feedback loops, not staff incompetence. We create the reporting and review cadence that turns billing into a managed process rather than a reactive one.
Payer mix management means deliberate strategy around which patients you acquire and which payers you contract with, not passive acceptance of whoever walks through the door. We model reimbursement by payer and product line, identify where your margin concentrates, and guide decisions on commercial contract negotiation, Medicaid volume limits, and patient acquisition spend. A 10% shift from Medicaid to commercial can double your margin in many DME categories.
We analyze turnover by SKU and category, separating fast-moving high-margin products from slow commodity items that tie up cash. The goal is not lower absolute inventory but optimized mix, where capital concentrates in products that turn quickly and generate margin. Most DME suppliers carry 60 to 90 days of slow-moving stock that could fund two additional turns of high-margin respiratory or wound care supplies.
Medicare dependence is common in DME and not disqualifying, but buyers will scrutinize your denial rate, days in A/R, and billing accuracy because reimbursement risk concentrates with a single payer. We document your claims accuracy rate, denial rate trend, and collections discipline to prove operational control. Buyers also want evidence of payer relationship transferability, which we build through documented contracts, compliance protocols, and non-owner payer communication history.
We build 13-week rolling cash forecasts that account for Medicare reimbursement lag, inventory replenishment cycles…
See the durable medical equipment suppliers angleProactive tax strategy for DME suppliers means aligning entity structure, owner compensation, and retirement vehicles…
See the durable medical equipment suppliers angleDME suppliers often overpay taxes by treating all owner earnings as W-2 salary, missing the after-tax advantage of…
See the durable medical equipment suppliers angleDME suppliers often reinvest in inventory or draw cash without a unified plan linking reimbursement volatility, payer…
See the durable medical equipment suppliers angleWe build a capital allocation framework that aligns debt, inventory investment, distribution timing, and working…
See the durable medical equipment suppliers angleDME suppliers pricing without job-level visibility lose margin to payer mix variation, billing denials, and delivery…
See the durable medical equipment suppliers angleFor DME suppliers, financial cleanliness means defensible billing records, documented denial workflows, inventory…
See the durable medical equipment suppliers angleExit readiness for a DME supplier means transforming billing accuracy, payer mix, inventory controls, and A/R hygiene…
See the durable medical equipment suppliers angleProduction per provider, collection rate, and payer mix. Dental practice value lives in the hygiene schedule a
See advisory angleProfitability by provider, location, and payer. Multi-provider groups live and die by payer mix and provider p
See advisory angleRepeat revenue, provider productivity, and margin per service line. Med spas are valued on whether the model r
See advisory angleThe Keystone Value Creation Assessment™ audits your last 12 to 36 months and gives you a written summary whether you engage us or not. If there is not a clear opportunity to create value, we will tell you directly.